Empress Therapeutics

Empress Therapeutics is a biotech company that is revolutionizing drug discovery by leveraging the power of genetics. Their Chemilogics™ platform utilizes genetic data, AI/ML, and co-evolution to generate better starting points for drugs. By identifying small molecules encoded in genetics and selected by co-evolution, Empress can predictably discover new chemical compounds at an unprecedented scale and speed. This unique approach allows them to develop potential drugs in months rather than years, bringing certainty and efficiency to the drug discovery process.

Empress is committed to developing impactful medicines for a wide range of diseases, including immune and inflammatory, metabolic, neurological, and cancer. Their initial portfolio of drug leads spans multiple structural classes and targets multiple classes of proteins. The company has already generated 15 molecules, across multiple target classes, for multiple indications, and expects to file multiple Investigational New Drug (IND) applications within the next 24 months.

Empress Therapeutics does not mention job flexibility or remote work options in their job postings or website content.

Empress Therapeutics is a biotechnology company dedicated to revolutionizing the drug discovery process by leveraging the power of genetics to source chemistry from within the human body. Their Chemilogics™ platform uses AI and synthetic biology to unlock the potential of small molecules encoded in genetic data, selected through co-evolution, enabling them to create effective and safe medicines more predictably and efficiently than traditional methods. This innovative approach promises to accelerate the development of new therapies for a wide range of diseases, ultimately improving patient outcomes.

Empress Therapeutics fosters a culture of innovation and collaboration among entrepreneurial scientists and creative optimists who are passionate about developing better medicines faster for patients. They encourage bold thinking and unconventional approaches to drug discovery, embracing the latest advancements in genomics, synthetic biology, and AI/ML. This collaborative environment thrives on the shared goal of making a tangible difference in human health.

Empress Therapeutics, founded by Flagship Pioneering, is committed to fostering a diverse, equitable, and inclusive workplace. They believe that diversity in backgrounds, perspectives, and experiences enriches their work and fosters innovation. This commitment is reflected in their statement on equal employment opportunities, which explicitly states that they do not discriminate on the basis of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity, or veteran status.